A Pharmacist and Health Coach-Delivered Mobile Health Intervention for Type 2 Diabetes: Protocol for a Randomized Controlled Crossover Study

Lisa Kay Sharp, Alana Biggers, Rosanne Perez, Julia Henkins, Jessica Tilton, Ben S Gerber, Lisa Kay Sharp, Alana Biggers, Rosanne Perez, Julia Henkins, Jessica Tilton, Ben S Gerber

Abstract

Background: Aggressive management of blood glucose, blood pressure, and cholesterol through medication and lifestyle adherence is necessary to minimize the adverse health outcomes of type 2 diabetes. However, numerous psychosocial and environmental barriers to adherence prevent low-income, urban, and ethnic minority populations from achieving their management goals, resulting in diabetes complications. Health coaches working with clinical pharmacists represent a promising strategy for addressing common diabetes management barriers. Mobile health (mHealth) tools may further enhance their ability to support vulnerable minority populations in diabetes management.

Objective: The aim of this study is to evaluate the impact of an mHealth clinical pharmacist and health coach-delivered intervention on hemoglobin A1c (HbA1c, primary outcome), blood pressure, and low-density lipoprotein (secondary outcomes) in African-Americans and Latinos with poorly controlled type 2 diabetes.

Methods: A 2-year, randomized controlled crossover study will evaluate the effectiveness of an mHealth diabetes intervention delivered by a health coach and clinical pharmacist team compared with usual care. All patients will receive 1 year of team intervention, including lifestyle and medication support delivered in the home with videoconferencing and text messages. All patients will also receive 1 year of usual care without team intervention and no home visits. The order of the conditions received will be randomized. Our recruitment goal is 220 urban African-American or Latino adults with uncontrolled type 2 diabetes (HbA1c ≥8%) receiving care from a largely minority-serving, urban academic medical center. The intervention includes the following: health coaches supporting patients through home visits, phone calls, and text messaging and clinical pharmacists supporting patients through videoconferences facilitated by health coaches. Data collection includes physiologic (HbA1c, blood pressure, weight, and lipid profile) and survey measures (medication adherence, diabetes-related behaviors, and quality of life). Data collection during the second year of study will determine the maintenance of any physiological improvement among participants receiving the intervention during the first year.

Results: Participant enrollment began in March 2017. We have recruited 221 patients. Intervention delivery and data collection will continue until November 2021. The results are expected to be published by May 2022.

Conclusions: This is among the first trials to incorporate health coaches, clinical pharmacists, and mHealth technologies to increase access to diabetes support among urban African-Americans and Latinos to achieve therapeutic goals.

International registered report identifier (irrid): DERR1-10.2196/17170.

Keywords: clinical pharmacists; community health workers; mHealth; type 2 diabetes mellitus.

Conflict of interest statement

Conflicts of Interest: None declared.

©Lisa Kay Sharp, Alana Biggers, Rosanne Perez, Julia Henkins, Jessica Tilton, Ben S Gerber. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 10.03.2021.

Figures

Figure 1
Figure 1
Randomized crossover study design.
Figure 2
Figure 2
Consolidated Standards of Reporting Trials flow diagram. mHealth: mobile health.

References

    1. Centers for Disease Control and Prevention National Diabetes Statistics Report. U.S. Department of Health and Human Services. 2017. [2021-02-21]. .
    1. Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K. Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol. 2018 Feb;6(2):130–42. doi: 10.1016/s2213-8587(17)30239-5.
    1. Murphy SL, Xu J, Kochanek KD, Arias E. Mortality in the United States, 2017. NCHS Data Brief. 2018 Nov;(328):1–8.
    1. Glantz NM, Duncan I, Ahmed T, Fan L, Reed BL, Kalirai S, Kerr D. Racial and ethnic disparities in the burden and cost of diabetes for US medicare beneficiaries. Health Equity. 2019 May;3(1):211–8. doi: 10.1089/heq.2019.0004.
    1. Smalls BL, Ritchwood TD, Bishu KG, Egede LE. Racial/ethnic differences in glycemic control in older adults with type 2 diabetes: United States 2003-2014. Int J Environ Res Public Health. 2020 Feb 04;17(3):950. doi: 10.3390/ijerph17030950.
    1. Preston SH, Choi D, Elo IT, Stokes A. Effect of diabetes on life expectancy in the United States by race and ethnicity. Biodemography Soc Biol. 2018 Dec 20;64(2):139–51. doi: 10.1080/19485565.2018.1542291.
    1. Kirk JK, Passmore LV, Bell RA, Narayan KV, D'Agostino RB, Arcury TA, Quandt SA. Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care. 2008 Feb 31;31(2):240–6. doi: 10.2337/dc07-0382.
    1. Casagrande SS, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013 Aug 15;36(8):2271–9. doi: 10.2337/dc12-2258.
    1. Shah BM, Mezzio DJ, Ho J, Ip EJ. Association of ABC (HbA1c, blood pressure, LDL-cholesterol) goal attainment with depression and health-related quality of life among adults with type 2 diabetes. J Diabetes Complications. 2015 Aug;29(6):794–800. doi: 10.1016/j.jdiacomp.2015.04.009.
    1. Casagrande SS, Aviles-Santa L, Corsino L, Daviglus ML, Gallo LC, Espinoza Giacinto RA, Llabre MM, Reina SA, Savage PJ, Schneiderman N, Talavera GA, Cowie CC. Hemoglobin A1C, blood pressure, and LDL-cholesterol control among Hispanic/Latino adults with diabetes: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Endocrine Practice. 2017 Oct;23(10):1232–53. doi: 10.4158/ep171765.or.
    1. American Diabetes Association Improving Care and Promoting Health in Populations: Dia Care. 2018 Dec 17;42(Supplement 1):S7–S12. doi: 10.2337/dc19-s001.
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 04;353(5):487–97. doi: 10.1056/nejmra050100.
    1. Haynes RB, Ackloo E, Sahota N, McDonald H, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2 doi: 10.1002/14651858.cd000011.pub3.
    1. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, Coker-Schwimmer EJ, Rosen DL, Sista P, Lohr KN. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012 Dec 04;157(11):785–95. doi: 10.7326/0003-4819-157-11-201212040-00538.
    1. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, Weissman JS. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010 Apr 4;25(4):284–90. doi: 10.1007/s11606-010-1253-9.
    1. Wanko NS, Brazier CW, Young-Rogers D, Dunbar VG, Boyd B, George CD, Rhee MK, el-Kebbi IM, Cook CB. Exercise preferences and barriers in urban African Americans with type 2 diabetes. Diabetes Educ. 2004 Sep 04;30(3):502–13. doi: 10.1177/014572170403000322.
    1. Marcy TR, Britton ML, Harrison D. Identification of barriers to appropriate dietary behavior in low-income patients with type 2 diabetes mellitus. Diabetes Ther. 2011 Mar 21;2(1):9–19. doi: 10.1007/s13300-010-0012-6.
    1. Bazargan-Hejazi S, Arroyo JS, Hsia S, Brojeni NR, Pan D. A racial comparison of differences between self-reported and objectively measured physical activity among US adults with diabetes. Ethn Dis. 2017 Dec 07;27(4):403–10. doi: 10.18865/ed.27.4.403.
    1. Vaccaro JA, Huffman FG. Sex and race/ethnicity differences in following dietary and exercise recommendations for U.S. representative sample of adults with type 2 diabetes. Am J Mens Health. 2017 Mar 07;11(2):380–91. doi: 10.1177/1557988316681126.
    1. Dahal PK, Hosseinzadeh H. Association of health literacy and diabetes self-management: a systematic review. Aust J Prim Health. 2019;25(6):526. doi: 10.1071/py19007.
    1. Thornton PL, Kumanyika SK, Gregg EW, Araneta MR, Baskin ML, Chin MH, Crespo CJ, de Groot M, Garcia DO, Haire-Joshu D, Heisler M, Hill-Briggs F, Ladapo JA, Lindberg NM, Manson SM, Marrero DG, Peek ME, Shields AE, Tate DF, Mangione CM. New research directions on disparities in obesity and type 2 diabetes. Ann N Y Acad Sci. 2020 Feb 03;1461(1):5–24. doi: 10.1111/nyas.14270.
    1. Huang ES, Brown SE, Thakur N, Carlisle L, Foley E, Ewigman B, Meltzer DO. Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care. 2009 Feb 18;32(2):311–6. doi: 10.2337/dc08-1307.
    1. Baghikar S, Benitez A, Fernandez Piñeros P, Gao Y, Baig AA. Factors impacting adherence to diabetes medication among urban, low income Mexican-Americans with diabetes. J Immigr Minor Health. 2019 Dec 23;21(6):1334–41. doi: 10.1007/s10903-019-00867-9.
    1. Gonzalez JS, Tanenbaum ML, Commissariat PV. Psychosocial factors in medication adherence and diabetes self-management: implications for research and practice. Am Psychol. 2016 Oct;71(7):539–51. doi: 10.1037/a0040388.
    1. Walker RJ, Strom Williams J, Egede LE. Influence of race, ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci. 2016 Apr;351(4):366–73. doi: 10.1016/j.amjms.2016.01.008.
    1. Lewey J, Shrank WH, Avorn J, Liu J, Choudhry NK. Medication adherence and healthcare disparities: impact of statin co-payment reduction. Am J Manag Care. 2015 Oct;21(10):696–704.
    1. Pawaskar MD, Xu L, Tang Y, Puckrein GA, Rajpathak SN, Stuart B. Effect of medication copayment on adherence and discontinuation in medicare beneficiaries with type 2 diabetes: a retrospective administrative claims database analysis. Diabetes Ther. 2018 Aug 24;9(5):1979–93. doi: 10.1007/s13300-018-0489-y.
    1. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007 Mar 26;167(6):540–50. doi: 10.1001/archinte.167.6.540.
    1. Bogner HR, de Vries HF. Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial. Diabetes Educ. 2010 Dec 29;36(2):284–92. doi: 10.1177/0145721709356115.
    1. Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. Prev Med. 2017 Jun;99:269–76. doi: 10.1016/j.ypmed.2017.03.008.
    1. Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients' medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018 Oct;26(5):387–97. doi: 10.1111/ijpp.12462.
    1. Doggrell SA. A review of interventions ≥ 6 months by pharmacists on adherence to medicines in cardiovascular disease: Characteristics of what works and what doesn't. Res Social Adm Pharm. 2019 Feb;15(2):119–29. doi: 10.1016/j.sapharm.2018.04.003.
    1. Community Preventive Services Task Force Team-based care to improve blood pressure control: recommendation of the Community Preventive Services Task Force. Am J Prev Med. 2014 Jul;47(1):100–2. doi: 10.1016/j.amepre.2014.03.003.
    1. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, Kerby TJ, Klotzle KJ, Maciosek MV, Michels RD, O'Connor PJ, Pritchard RA, Sekenski JL, Sperl-Hillen JM, Trower NK. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. J Am Med Assoc. 2013 Jul 03;310(1):46–56. doi: 10.1001/jama.2013.6549.
    1. Antoine SL, Pieper D, Mathes T, Eikermann M. Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials. BMC Endocr Disord. 2014 Jul 7;14(1) doi: 10.1186/1472-6823-14-53.
    1. Deters MA, Laven A, Castejon A, Doucette WR, Ev LS, Krass I, Mehuys E, Obarcanin E, Schwender H, Laeer S. Effective interventions for diabetes patients by community pharmacists: a meta-analysis of pharmaceutical care components. Ann Pharmacother. 2018 Feb 26;52(2):198–211. doi: 10.1177/1060028017733272.
    1. Iyer R, Coderre P, McKelvey T, Cooper J, Berger J, Moore E, Kushner M. An employer-based, pharmacist intervention model for patients with type 2 diabetes. Am J Health Syst Pharm. 2010 Feb 15;67(4):312–6. doi: 10.2146/ajhp090047.
    1. Rochester CD, Leon N, Dombrowski R, Haines ST. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2010 Jan 01;67(1):42–8. doi: 10.2146/ajhp080706.
    1. Taveira TH, Friedmann PD, Cohen LB, Dooley AG, Khatana SAM, Pirraglia PA, Wu W. Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes Educ. 2010 Dec 04;36(1):109–17. doi: 10.1177/0145721709352383.
    1. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11 doi: 10.1002/14651858.cd000011.pub4.
    1. Viswanathan M, Kahwati LC, Golin CE, Blalock SJ, Coker-Schwimmer E, Posey R, Lohr KN. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015 Jan 01;175(1):76–87. doi: 10.1001/jamainternmed.2014.5841.
    1. Chung N, Rascati K, Lopez D, Jokerst J, Garza A. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population. J Manag Care Spec Pharm. 2014 Sep;20(9):914–9. doi: 10.18553/jmcp.2014.20.9.914.
    1. Fazel MT, Bagalagel A, Lee JK, Martin JR, Slack MK. Impact of diabetes care by pharmacists as part of health care team in ambulatory settings: a systematic review and meta-analysis. Ann Pharmacother. 2017 Oct 02;51(10):890–907. doi: 10.1177/1060028017711454.
    1. Skinner JS, Poe B, Hopper R, Boyer A, Wilkins CH. Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes. Diabetes Educ. 2015 Aug 25;41(4):459–65. doi: 10.1177/0145721715587563.
    1. Bluml BM, Watson LL, Skelton JB, Manolakis PG, Brock KA. Improving outcomes for diverse populations disproportionately affected by diabetes: Final results of Project IMPACT: Diabetes. J Am Pharm Assoc. 2014 Sep;54(5):477–85. doi: 10.1331/japha.2014.13240.
    1. Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A, Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J, Patel L, Khan NF, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD. Effect of a remotely delivered tailored multicomponent approach to enhance medication taking for patients with hyperlipidemia, hypertension, and diabetes. JAMA Intern Med. 2018 Sep 01;178(9):1182. doi: 10.1001/jamainternmed.2018.3189.
    1. Lauffenburger JC, Ghazinouri R, Jan S, Makanji S, Ferro CA, Lewey J, Wittbrodt E, Lee J, Haff N, Fontanet CP, Choudhry NK. Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial. PLoS One. 2019 Apr 2;14(4):e0214754. doi: 10.1371/journal.pone.0214754.
    1. Gary TL, Batts-Turner M, Yeh H, Hill-Briggs F, Bone LR, Wang N, Levine DM, Powe NR, Saudek CD, Hill MN, McGuire M, Brancati FL. The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med. 2009 Oct 26;169(19):1788–94. doi: 10.1001/archinternmed.2009.338.
    1. Sherifali D, Viscardi V, Bai J, Ali RMU. Evaluating the Effect of a Diabetes Health Coach in Individuals with Type 2 Diabetes. Can J Diabetes. 2016 Feb;40(1):84–94. doi: 10.1016/j.jcjd.2015.10.006.
    1. Wayne N, Perez DF, Kaplan DM, Ritvo P. Health coaching reduces HbA1c in type 2 diabetic patients from a lower-socioeconomic status community: a randomized controlled trial. J Med Internet Res. 2015 Oct 05;17(10):e224. doi: 10.2196/jmir.4871.
    1. Rothschild SK, Martin MA, Swider SM, Tumialán Lynas CM, Janssen I, Avery EF, Powell LH. Mexican American trial of community health workers: a randomized controlled trial of a community health worker intervention for Mexican Americans with type 2 diabetes mellitus. Am J Public Health. 2014 Aug;104(8):1540–8. doi: 10.2105/ajph.2013.301439.
    1. Thom DH, Ghorob A, Hessler D, De Vore D, Chen E, Bodenheimer TA. Impact of peer health coaching on glycemic control in low-income patients with diabetes: a randomized controlled trial. Ann Fam Med. 2013 Mar 18;11(2):137–44. doi: 10.1370/afm.1443.
    1. Hughes MM, Yang E, Ramanathan D, Benjamins MR. Community-based diabetes community health worker intervention in an underserved Chicago population. J Community Health. 2016 Dec 10;41(6):1249–56. doi: 10.1007/s10900-016-0212-8.
    1. Pirbaglou M, Katz J, Motamed M, Pludwinski S, Walker K, Ritvo P. Personal health coaching as a type 2 diabetes mellitus self-management strategy: a systematic review and meta-analysis of randomized controlled trials. Am J Health Promot. 2018 Sep 15;32(7):1613–26. doi: 10.1177/0890117118758234.
    1. DePue JD, Dunsiger S, Seiden AD, Blume J, Rosen RK, Goldstein MG, Nu'usolia O, Tuitele J, McGarvey ST. Nurse-community health worker team improves diabetes care in American Samoa: results of a randomized controlled trial. Diabetes Care. 2013 Jul 07;36(7):1947–53. doi: 10.2337/dc12-1969.
    1. Sharp LK, Tilton JJ, Touchette DR, Xia Y, Mihailescu D, Berbaum ML, Gerber BS. Community health workers supporting clinical pharmacists in diabetes management: a randomized controlled trial. Pharmacotherapy. 2018 Jan 30;38(1):58–68. doi: 10.1002/phar.2058.
    1. Zhai Y, Zhu W, Cai Y, Sun D, Zhao J. Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus. Medicine. 2014;93(28):e312. doi: 10.1097/md.0000000000000312.
    1. Verhoeven F, van Gemert-Pijnen L, Dijkstra K, Nijland N, Seydel E, Steehouder M. The contribution of teleconsultation and videoconferencing to diabetes care: a systematic literature review. J Med Internet Res. 2007 Dec 14;9(5):e37. doi: 10.2196/jmir.9.5.e37.
    1. Lee SWH, Chan CKY, Chua SS, Chaiyakunapruk N. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: a systematic review and network meta-analysis. Sci Rep. 2017 Oct 4;7(1) doi: 10.1038/s41598-017-12987-z.
    1. Dick JJ, Nundy S, Solomon MC, Bishop KN, Chin MH, Peek ME. Feasibility and usability of a text message-based program for diabetes self-management in an urban African-American population. J Diabetes Sci Technol. 2011 Sep 01;5(5):1246–54. doi: 10.1177/193229681100500534.
    1. Carpenter R, DiChiacchio T, Barker K. Interventions for self-management of type 2 diabetes: an integrative review. Int J Nurs Sci. 2019 Jan 10;6(1):70–91. doi: 10.1016/j.ijnss.2018.12.002.
    1. Baron JS, Hirani SP, Newman SP. Investigating the behavioural effects of a mobile-phone based home telehealth intervention in people with insulin-requiring diabetes: Results of a randomized controlled trial with patient interviews. J Telemed Telecare. 2016 Jul 03;23(5):503–12. doi: 10.1177/1357633x16655911.
    1. Lee PA, Greenfield G, Pappas Y. The impact of telehealth remote patient monitoring on glycemic control in type 2 diabetes: a systematic review and meta-analysis of systematic reviews of randomised controlled trials. BMC Health Serv Res. 2018 Jun 26;18(1):495. doi: 10.1186/s12913-018-3274-8.
    1. Hartz J, Yingling L, Powell-Wiley TM. Use of mobile health technology in the prevention and management of diabetes mellitus. Curr Cardiol Rep. 2016 Dec 8;18(12):130. doi: 10.1007/s11886-016-0796-8.
    1. Tomlinson M, Rotheram-Borus MJ, Swartz L, Tsai AC. Scaling up mHealth: where is the evidence? PLoS Med. 2013;10(2):e1001382. doi: 10.1371/journal.pmed.1001382.
    1. Head KJ, Noar SM, Iannarino NT, Harrington NG. Efficacy of text messaging-based interventions for health promotion: a meta-analysis. Soc Sci Med. 2013 Nov;97:41–8. doi: 10.1016/j.socscimed.2013.08.003.
    1. Wallace LS, Rogers ES, Roskos SE, Holiday DB, Weiss BD. Brief report: screening items to identify patients with limited health literacy skills. J Gen Intern Med. 2006 Aug;21(8):874–7. doi: 10.1111/j.1525-1497.2006.00532.x.
    1. Nundy S, Razi RR, Dick JJ, Smith B, Mayo A, O'Connor A, Meltzer DO. A text messaging intervention to improve heart failure self-management after hospital discharge in a largely African-American population: before-after study. J Med Internet Res. 2013 Mar 11;15(3):e53. doi: 10.2196/jmir.2317.
    1. Recommendations for managing type 2 diabetes in primary care. International Diabetes Federation. 2017. [2021-02-10]. .
    1. American Diabetes Association. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008 Jan;31 Suppl 1:S61–78. doi: 10.2337/dc08-S061.
    1. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White DL. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006 Jun;29(6):1433–8. doi: 10.2337/dc06-9910.
    1. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003 Jun;26(6):1902–12. doi: 10.2337/diacare.26.6.1902.
    1. Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6(3):246–52. doi: 10.1370/afm.842.
    1. Levis B, Benedetti A, Thombs BD, DEPRESsion Screening Data (DEPRESSD) Collaboration Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. Br Med J. 2019 Apr 09;365:l1476. doi: 10.1136/bmj.l1476.
    1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606–13. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009 Apr;114(1-3):163–73. doi: 10.1016/j.jad.2008.06.026.
    1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Cholestrol Clinical Practice Guidelines. [2021-02-11]. .
    1. Berthold T. Foundations of community health workers, 2nd ed. U.S: Bookbyte; 2016.
    1. Sherifali D. Diabetes coaching for individuals with type 2 diabetes: a state-of-the-science review and rationale for a coaching model. J Diabetes. 2017 Jun;9(6):547–54. doi: 10.1111/1753-0407.12528.
    1. Islam N, Shapiro E, Wyatt L, Riley L, Zanowiak J, Ursua R, Trinh-Shevrin C. Evaluating community health workers' attributes, roles, and pathways of action in immigrant communities. Prev Med. 2017 Oct;103:1–7. doi: 10.1016/j.ypmed.2017.07.020.
    1. Midwest Latino Health Research TrainingPolicy Center. Diabetes Education and Empowerment Program (DEEP) - 3rd ed. Midwest Latino Health Research Training Policy Center. [2020-12-13].
    1. Ghorob A, Vivas MM, De Vore D, Ngo V, Bodenheimer T, Chen E, Thom DH. The effectiveness of peer health coaching in improving glycemic control among low-income patients with diabetes: protocol for a randomized controlled trial. BMC Public Health. 2011 Apr 01;11:208. doi: 10.1186/1471-2458-11-208.
    1. Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Fischl AH, Maryniuk MD, Siminerio L, Vivian E. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the american diabetes association, the american association of diabetes educators, and the academy of nutrition and dietetics. Clin Diabetes. 2016 Apr;34(2):70–80. doi: 10.2337/diaclin.34.2.70.
    1. Gerber BS, Brodsky IG, Lawless KA, Smolin LI, Arozullah AM, Smith EV, Berbaum ML, Heckerling PS, Eiser AR. Implementation and evaluation of a low-literacy diabetes education computer multimedia application. Diabetes Care. 2005 Jul;28(7):1574–80. doi: 10.2337/diacare.28.7.1574.
    1. Locke EA, Latham GP. New developments in goal setting and task performance. New York: Routledge; 2013.
    1. Goldman ML, Ghorob A, Hessler D, Yamamoto R, Thom DH, Bodenheimer T. Are low-income peer health coaches able to master and utilize evidence-based health coaching? Ann Fam Med. 2015 Aug;13 Suppl 1:S36–41. doi: 10.1370/afm.1756.
    1. American College of Physicians. Chicago: American College of Physicians; 2017. Living with diabetes: an everyday guide for you and your family.
    1. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, REDCap Consortium The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208.
    1. Krause NM, Jay GM. What do global self-rated health items measure? Med Care. 1994 Sep;32(9):930–42. doi: 10.1097/00005650-199409000-00004.
    1. Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004 Sep;36(8):588–94.
    1. Sarkar U, Schillinger D, López A, Sudore R. Validation of self-reported health literacy questions among diverse English and Spanishspeaking populations. J Gen Intern Med. 2011 Mar;26(3):265–71. doi: 10.1007/s11606-010-1552-1.
    1. Bradley C, Brewin C, Gamsu D, Moses J. Development of scales to measure perceived control of diabetes mellitus and diabetes-related health beliefs. Diabet Med September 01. 1984;1(3):213–8. doi: 10.1111/j.1464-5491.1984.tb01955.x.
    1. Tang TS, Brown MB, Funnell MM, Anderson RM. Social support, quality of life, and self-care behaviors amongAfrican Americans with type 2 diabetes. Diabetes Educ. 2008;34(2):266–76. doi: 10.1177/0145721708315680.
    1. Lorig K, Ritter PL, Villa FJ, Armas J. Community-based peer-led diabetes self-management: a randomized trial. Diabetes Educ. 2009;35(4):641–51. doi: 10.1177/0145721709335006.
    1. Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT. A short scale for measuring loneliness in large surveys: results from two population-based studies. Res Aging. 2004;26(6):655–72. doi: 10.1177/0164027504268574.
    1. York Cornwell E, Cagney KA. Assessment of neighborhood context in a nationally representative study. J Gerontol B Psychol Sci Soc Sci. 2014 Nov;69 Suppl 2:S51–63. doi: 10.1093/geronb/gbu052.
    1. Kowitt SD, Donahue KE, Fisher EB, Mitchell M, Young LA. How is neighborhood social disorganization associated with diabetes outcomes? A multilevel investigation of glycemic control and self-reported use of acute or emergency health care services. Clin Diabetes Endocrinol. 2018;4:19. doi: 10.1186/s40842-018-0069-0.
    1. Anderson TS, Jing B, Auerbach A, Wray CM, Lee S, Boscardin WJ, Fung K, Ngo S, Silvestrini M, Steinman MA. Clinical outcomes after intensifying antihypertensive medication regimens among older adults at hospital discharge. JAMA Intern Med. 2019 Aug 19; doi: 10.1001/jamainternmed.2019.3007.
    1. Giugliano D, Maiorino MI, Bellastella G, Esposito K. Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes. J Endocrinol Invest. 2019 May;42(5):495–503. doi: 10.1007/s40618-018-0951-8.
    1. Billue KL, Safford MM, Salanitro AH, Houston TK, Curry W, Kim Y, Allison JJ, Estrada CA. Medication intensification in diabetes in rural primary care: a cluster-randomised effectiveness trial. BMJ Open. 2012;2(5) doi: 10.1136/bmjopen-2012-000959.
    1. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000 Jul;23(7):943–50. doi: 10.2337/diacare.23.7.943.
    1. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007 Jul;31(7):1208–17. doi: 10.1111/j.1530-0277.2007.00403.x.
    1. Vas A, Devi ES, Vidyasagar S, Acharya R, Rau NR, George A, Jose T, Nayak B. Effectiveness of self-management programmes in diabetes management: a systematic review. Int J Nurs Pract. 2017 Oct;23(5) doi: 10.1111/ijn.12571.
    1. Rochon J. Sample size calculations for two-group repeated-measures experiments. Biometrics. 1991 Dec;47(4):1383. doi: 10.2307/2532393.
    1. Little RJA, Rubin DB. Statistical analysis with missing data, 2nd Edition. Hoboken, NJ: John Wiley & Sons, Inc; 2014.
    1. Little R, Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics. 1996 Dec;52(4):1324. doi: 10.2307/2532847.
    1. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. Br Med J. 1999 Sep 11;319(7211):670–4. doi: 10.1136/bmj.319.7211.670.
    1. Lachin JM. Statistical considerations in the intent-to-treat principle. Controlled Clinical Trials. 2000 Jun;21(3):167–89. doi: 10.1016/s0197-2456(00)00046-5.
    1. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006 Dec 07;355(23):2427–43. doi: 10.1056/nejmoa066224.
    1. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. New York: Oxford University Press; 2000. p. A.
    1. Jones B, Kenward MG. Design and analysis of cross-over trials. London: Chapman and Hall; 1989.
    1. Tabachnick BG, Fidell LS. Using multivariate statistics (5th Edition) US: Allyn & Bacon, Inc; 2007.
    1. Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010 Aug 12;11:85. doi: 10.1186/1745-6215-11-85.
    1. Kaplan SH, Billimek J, Sorkin DH, Ngo-Metzger Q, Greenfield S. Who can respond to treatment? Medical Care. 2010;48:S9–S16. doi: 10.1097/mlr.0b013e3181d99161.
    1. Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82. doi: 10.1037/0022-3514.51.6.1173.
    1. Fairchild AJ, MacKinnon DP. A general model for testing mediation and moderation effects. Prev Sci. 2009 Jun;10(2):87–99. doi: 10.1007/s11121-008-0109-6.
    1. Muthén LK, Muthén BO. Mplus User's Guide. Sixth edition ed. Los Angeles, CA: Muthén & Muthén; 2010. [2021-02-21]. .
    1. MacKinnon D. Introduction to statistical mediation analysis. New York: Lawrence Erlbaum Associates; 2008.
    1. Efron B. Better bootstrap confidence intervals. J Am Stat Assoc. 1987 Mar;82(397):171–85. doi: 10.1080/01621459.1987.10478410.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe